X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (957) 957
Publication (39) 39
Magazine Article (13) 13
Book Review (6) 6
Book Chapter (4) 4
Newsletter (3) 3
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (660) 660
reserpine - adverse effects (502) 502
male (369) 369
female (321) 321
animals (308) 308
reserpine - therapeutic use (262) 262
reserpine (204) 204
hypertension - drug therapy (202) 202
middle aged (191) 191
rats (188) 188
adult (167) 167
reserpine - pharmacology (164) 164
aged (149) 149
index medicus (93) 93
antihypertensive agents - adverse effects (91) 91
reserpine - administration & dosage (88) 88
pharmacology & pharmacy (83) 83
antihypertensive agents - therapeutic use (71) 71
mice (70) 70
time factors (65) 65
drug therapy, combination (64) 64
neurosciences (61) 61
blood pressure - drug effects (60) 60
breast neoplasms - chemically induced (59) 59
depression - chemically induced (54) 54
dose-response relationship, drug (51) 51
corticosteroids (50) 50
methyldopa - therapeutic use (49) 49
methyldopa - adverse effects (46) 46
pregnancy (45) 45
chlorpromazine - adverse effects (43) 43
antipsychotic agents - adverse effects (42) 42
medicine, general & internal (42) 42
disease models, animal (41) 41
psychiatry (41) 41
hydralazine - therapeutic use (40) 40
drug synergism (38) 38
guanethidine - therapeutic use (38) 38
dopamine - metabolism (37) 37
clinical trials as topic (35) 35
secologanin tryptamine alkaloids - adverse effects (35) 35
rats, sprague-dawley (34) 34
diuretics - therapeutic use (33) 33
drug interactions (33) 33
age factors (32) 32
dopamine (32) 32
clinical neurology (31) 31
diuretics (31) 31
drug-related side effects and adverse reactions (31) 31
rats, wistar (31) 31
hypertension - complications (30) 30
dyskinesia, drug-induced - drug therapy (29) 29
guanethidine - adverse effects (29) 29
hypertension (29) 29
adolescent (28) 28
blood pressure (28) 28
diuretics - adverse effects (28) 28
serotonin (28) 28
antihypertensive agents - administration & dosage (27) 27
depression (27) 27
tranquilizing agents - adverse effects (27) 27
phenothiazines - adverse effects (26) 26
propranolol - adverse effects (26) 26
antihypertensive agents (25) 25
brain (25) 25
rabbits (25) 25
serotonin - metabolism (25) 25
antidepressants (24) 24
hydralazine - adverse effects (24) 24
parkinson disease - drug therapy (24) 24
risk (24) 24
dogs (23) 23
motor activity - drug effects (23) 23
propranolol - therapeutic use (23) 23
benzothiadiazines (22) 22
clonidine - adverse effects (22) 22
depression - drug therapy (22) 22
depression, mental (22) 22
schizophrenia - drug therapy (22) 22
analysis (21) 21
drugs (21) 21
haloperidol - adverse effects (21) 21
hypertension - physiopathology (21) 21
oxidative stress (21) 21
research (21) 21
aspirin - adverse effects (20) 20
brain - metabolism (20) 20
drug combinations (20) 20
hydrochlorothiazide - therapeutic use (20) 20
parkinson disease, secondary - chemically induced (20) 20
rats, inbred strains (20) 20
stomach ulcer - chemically induced (20) 20
adrenergic beta-antagonists - adverse effects (19) 19
heart rate - drug effects (19) 19
research article (19) 19
administration, oral (18) 18
child (18) 18
clonidine - therapeutic use (18) 18
dyskinesia, drug-induced - etiology (18) 18
movement disorders - chemically induced (18) 18
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (717) 717
German (79) 79
French (46) 46
Italian (34) 34
Russian (26) 26
Japanese (22) 22
Polish (12) 12
Spanish (12) 12
Czech (7) 7
Dutch (6) 6
Swedish (6) 6
Slovak (5) 5
Chinese (4) 4
Danish (4) 4
Finnish (3) 3
Bulgarian (2) 2
Hebrew (2) 2
Norwegian (2) 2
Portuguese (2) 2
Afrikaans (1) 1
Croatian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Psychopharmacology, ISSN 0269-8811, 4/2013, Volume 27, Issue 4, pp. 374 - 385
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 13819 - 14
With increased usage of cardiovascular drugs (CVDs) for treating cardiovascular diseases, it is important to analyze CVD-associated adverse events (AEs). In... 
BLOCKERS | SIGNAL-DETECTION | STATIN THERAPY | SAFETY | MULTIDISCIPLINARY SCIENCES | MECHANISMS | MEDICINES | HEART-DISEASE MORTALITY | GENE ONTOLOGY | COENZYME-Q10 | DECLINE | Anorexia | Statistical analysis | Indapamide | Digoxin | Ontology | Case reports | Diarrhea | Cardiovascular diseases | Reserpine
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 01/2015, Volume 746, pp. 293 - 300
High prevalence of psychological comorbidities such as depression and anxiety in patients with inflammatory bowel disease (IBD) supports the premise that... 
Colitis | Rat | Fluvoxamine | Depressive disorders | Reserpine | ULCERATIVE-COLITIS | SUSCEPTIBILITY | FLUOXETINE | COMORBIDITY | ANTIDEPRESSANTS | INFLAMMATORY-BOWEL-DISEASE | REACTIVATION | MOUSE MODEL | PHARMACOLOGY & PHARMACY | RECEPTORS | TNBS-INDUCED COLITIS | Colon - enzymology | Reserpine - adverse effects | Rats, Wistar | Antipsychotic Agents - adverse effects | Reserpine - therapeutic use | Colon - drug effects | Gastrointestinal Agents - administration & dosage | Colon - immunology | Male | Antidepressive Agents, Second-Generation - administration & dosage | Antidepressive Agents, Second-Generation - therapeutic use | Colitis, Ulcerative - psychology | Neutrophil Infiltration | Colitis, Ulcerative - immunology | Peroxidase - chemistry | Intestinal Mucosa - drug effects | Dose-Response Relationship, Drug | Depression - drug therapy | Reserpine - administration & dosage | Fluvoxamine - administration & dosage | Antipsychotic Agents - therapeutic use | Intestinal Mucosa - immunology | Intestinal Mucosa - enzymology | Depression - complications | Colitis, Ulcerative - drug therapy | Drug Resistance | Disease Models, Animal | Peroxidase - antagonists & inhibitors | Fluvoxamine - therapeutic use | Colon - pathology | Colitis, Ulcerative - pathology | Random Allocation | Fluvoxamine - adverse effects | Antipsychotic Agents - administration & dosage | Dexamethasone - therapeutic use | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Gastrointestinal Agents - therapeutic use | Gastrointestinal Agents - adverse effects | Intestinal Mucosa - pathology | Peroxidase - metabolism | Medical colleges | Dexamethasone | Antidepressants | Comorbidity | Gastrointestinal diseases | Depression, Mental | Acetic acid | Organic acids
Journal Article
Journal Article
Psychopharmacology, ISSN 0033-3158, 12/2011, Volume 218, Issue 4, pp. 733 - 748
There is increased interest in elucidating the range of symptoms of schizophrenia and their response to treatment with medications. Particularly negative and... 
Antipsychotics | Neurosciences | Biomedicine | Dopamine | Healthy volunteers | Psychopathology | Haloperidol | Pharmacology/Toxicology | Aripiprazole | Psychiatry | Reserpine | PSYCHIATRY | AFFECTIVE-DISORDERS | RANDOMIZED-TRIAL | SCHIZOPHRENIA | NEGATIVE SYNDROME SCALE | NEUROSCIENCES | D-2 RECEPTOR OCCUPANCY | SUBJECTIVE EXPERIENCE | PHARMACOLOGY & PHARMACY | QUALITY-OF-LIFE | DOPAMINE-D-2 RECEPTORS | INDUCED AKATHISIA | RATING-SCALE | Piperazines - administration & dosage | Single-Blind Method | Reserpine - adverse effects | Antipsychotic Agents - adverse effects | Humans | Haloperidol - administration & dosage | Male | Quinolones - pharmacology | Young Adult | Psychiatric Status Rating Scales | Reserpine - administration & dosage | Quinolones - adverse effects | Reserpine - pharmacology | Adult | Female | Haloperidol - pharmacology | Dopamine - metabolism | Basal Ganglia Diseases - chemically induced | Haloperidol - adverse effects | Piperazines - adverse effects | Piperazines - pharmacology | Antipsychotic Agents - administration & dosage | Quinolones - administration & dosage | Antipsychotic Agents - pharmacology | Psychological aspects | Schizophrenia | Corticosteroids | Toy industry | Health | Motor ability | Placebo effect | Volunteers | Emotional behavior | Neuroleptics | Extrapyramidal system | Mental disorders | Cognitive ability | Depression | Psychosis | Side effects
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 04/2016, Volume 2016, Issue 4, pp. CD012122 - CD012122
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 09/2012, Volume 691, Issue 1-3, pp. 46 - 51
Journal Article